BURROWS FRANCIS (Chief Scientific Officer) sold 32.9% of their position (20.73K shares) of KURA ONCOLOGY, INC. on the open market
Open‑market sale worth $224.5K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/25/2026ACC: 0001193125-26-402815
Officer· Chief Scientific Officer
Since Jan 2026
-20.73K
Net shares
Net seller
$224.5K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
30K acquired · 50.73K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+30K
Price / share
$6.15
Trade value
$184.50K
% of position
90.8%
9/24/2026
33.05K→63.05K
Common Stock
Direct
Shares
−20.73K
Price / share
$10.83
Trade value
$224.51K
% of position
32.9%
9/24/2026
63.05K→42.33K
Total
Net shares
+9.27K
Net value
-$40.01K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/24/2026 | M · Option Exercise | +30K | $6.15 | $184.50K | 90.8% | 33.05K | 63.05K |
| Common Stock Direct | 9/24/2026 | S · Sale | −20.73K | $10.83 | $224.51K | 32.9% | 63.05K | 42.33K |
| Total | +9.27K | -$40.01K | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common stock
30K shares
Shares
−30K
Strike price
6.15
Held after
0.00
Exercisable
—
9/24/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common stock30K shares | 9/24/2026 | M · Option Exercise | −30K | 6.15 | — | 0.00 |